C-MER Eye Care Holdings Limited
Symboli: 3309.HK
HKSE
3.11
HKDMarkkinahinta tänään
62.7191
P/E-suhde
0.0000
PEG-suhde
3.87B
MRK Cap
- 0.00%
DIV Tuotto
C-MER Eye Care Holdings Limited (3309-HK) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 557.4 | 698.5 | 442.4 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 44.7 | 53.8 | 55.7 | ||||||||||
balance-sheet.row.net-receivables | 0 | 66.7 | 53.9 | 30.1 | ||||||||||
balance-sheet.row.inventory | 0 | 42 | 55.6 | 34.5 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 54.1 | 48.6 | 239.5 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 720.1 | 856.6 | 746.4 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1000.3 | 1057.6 | 901.3 | ||||||||||
balance-sheet.row.goodwill | 0 | 530.4 | 540.7 | 195 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 558.2 | 821.4 | 204 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1088.6 | 1362.1 | 398.9 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 193.1 | 129.2 | 77.4 | ||||||||||
balance-sheet.row.tax-assets | 0 | 6.8 | 6.9 | 11 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | -260.3 | -510.7 | -179.1 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2028.5 | 2045.1 | 1209.5 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.account-payables | 0 | 54.9 | 45.3 | 39.9 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 116.5 | 149.3 | 265.5 | ||||||||||
balance-sheet.row.tax-payables | 0 | 24 | 18.9 | 8.5 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 13.8 | 21.2 | 7.6 | ||||||||||
Deferred Revenue Non Current | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 163.7 | 290.7 | 92.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 366 | 378.6 | 210.4 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.total-liab | 0 | 755.3 | 903.4 | 618.6 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 1520.5 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 125.6 | 126.7 | 115 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 77.4 | 26.6 | 50.5 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -3.1 | 9.6 | 79 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 125.6 | 1703.2 | 1086.7 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1845.8 | 1866.1 | 1331.2 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 147.5 | 132.2 | 6 | ||||||||||
balance-sheet.row.total-equity | 0 | 1993.3 | 1998.2 | 1337.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 237.7 | 183 | 133.1 | ||||||||||
balance-sheet.row.total-debt | 0 | 363 | 452.5 | 471.7 | ||||||||||
balance-sheet.row.net-debt | 0 | -149.8 | -192.2 | 85 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 62 | -21.9 | 21.9 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 223.7 | 148.6 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -483.2 | -309.4 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 1.3 | 4.3 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -32.7 | -7.4 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | -26.7 | -18.5 | ||||||||||
cash-flows.row.inventory | 0 | 0 | -8.7 | -9.2 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 0.9 | 19.7 | ||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 1.7 | 0.6 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -62.1 | 504.6 | 290.6 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | -80.3 | -223.5 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -39.2 | -40 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 106.7 | 277.6 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -106.7 | -277.6 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -210.7 | -392.7 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -162 | -174.4 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 607.7 | 9.2 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -29.9 | -88.6 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -132.9 | -23 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -1.2 | 354.9 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 281.6 | 78.1 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -4.8 | -1.1 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 258 | -167.3 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 644.7 | 644.7 | 386.7 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 644.7 | 386.7 | 553.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 191.9 | 148.4 | ||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 100.6 | 19.2 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1924 | 1731.9 | 1112.6 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1381.5 | 1366.6 | 803.1 | ||||||||||
income-statement-row.row.gross-profit | 0 | 542.5 | 365.3 | 309.4 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 426 | 389.8 | 311.8 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1807.5 | 1756.3 | 1114.9 | ||||||||||
income-statement-row.row.interest-income | 0 | 19.9 | 7.1 | 4.5 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 220.7 | 223.7 | 148.6 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 116.4 | -24.4 | -2.3 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 121.1 | -49 | 16.2 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 37.9 | 35 | 10.6 | ||||||||||
income-statement-row.row.net-income | 0 | 62 | -21.9 | 21.9 |
Usein kysytty kysymys
Mikä on C-MER Eye Care Holdings Limited (3309.HK) taseen loppusumma?
C-MER Eye Care Holdings Limited (3309.HK) kokonaisvarat ovat 2748635000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.282.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 0.215.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.032.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.060.
Mikä on C-MER Eye Care Holdings Limited (3309.HK) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 61998000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 362990000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 426032000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.